Predementia cognitive disorders: modern approaches to terminology, diagnosis and treatment


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Predementia cognitive disorders (PDCDs) are a heterogeneous group of states with variable course, prognosis, and key clinical symptoms. This article presents a modern understanding of the terminology and criteria for the diagnosis of PDCDs, their clinical features; the concepts of subjective cognitive impairment and partial type of mild cognitive impairment are introduced. The difficulties of their identification are associated with insufficient data on the degree of permissible functional decline and the features of daily activity in various variants of cognitive disorders. Given the frequent absence of the responsible informant, especially in the conditions of hospitalization, a scale for assessing daily activity in the hospital is proposed. Differentiated approach to the diagnosis of PDCDs will optimize the treatment of patients and improve their quality of life.

全文:

受限制的访问

作者简介

Elena Vasenina

Russian Medical Academy of Continuous Professional Education

Email: hel_vas@mail.ru
PhD, Associate Professor at the Department of Neurology RMACPE

D. Gutorova

Hospital for War Veterans № 1, Moscow

I. Smirnova

S.P. Botkin City Clinical Hospital

O. Levin

Russian Medical Academy of Continuous Professional Education

参考

  1. Васенина Е.Е., Левин О.С., Сонин А.Г Современные тенденции в эпидемиологии деменции и ведении пациентов с когнитивными нарушениями. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуск. 2017;117(6): 87-95. Doi: 10.17116/ jnevro20171176287-95.
  2. Minett T., Brayne C. Epidemiology of dementia. Oxford Textbook of Cognitive Neurology and Dementia. 2016. P. 211-20. Doi:10.1093/ med/9780199655946.003.0020.
  3. Левин О.С. Диагностика и лечение деменции в клинической практике. М., 2014.256с.
  4. Lopez O.L., Jagust W.J., DeKosky S.T., et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch. Neurol. 2003;60(10):1385-89.
  5. Jessen F., Wolfsgruber S., Wiese B., et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2013. Doi:10.1016/j. jalz.2012.09.017.
  6. Jessen F., Wiese B., Bachmann C., et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch. Gen. Psychiatry. 2010;67(4):414-22.
  7. Mitchell A.J. The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and demntia: a meta-analysis. Int. J. Geriatr. Psychiatry. 2008;23(11):1191-202.
  8. McCarthy P., Benuskova L., Franz E.A. The agerelated posterior-anterior shift as revealed by voxelwise analysis of functional brain networks. Frontiers in Aging Neuroscience, 2014;6. doi: 10.3389/fnagi.2014.00301.
  9. Anon. Association between cerebral amyloid deposition and cognitive function in geriatric depression: pilot study using amyloid PET Int. J. Neuropsychopharmacol. 2016;19(Suppl. 1):10-10. doi: 10.1093/ijnp/pyw044.569.
  10. Левин О.С., Васенина Е.Е., Ганькина О.А. Диагностика и лечение умеренного когнитивного расстройства. Современная терапия в психиатрии и неврологии. 2014;4. URL: https://cyberleninka.ru/article/n/diagnostika-i-lechenie-umerennogo-kognitivnogo-rasstroystva.
  11. Loewenstein D.A., Greig M.T., Schinka J.A., et al. An investigation of PreMCI: subtypes and longitudinal outcomes. Alzheimers Dement. 2012; 8(3):172-79.
  12. Ghosh Sayantani, Libon David, Lippa Carol, et al. Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm. Am. J. Alzh. Disease Other Dementias. 2013;XX(X):1-10.
  13. Luck T., Luppa M., Briel S., Riedel-Heller S.G. Incidence of mild cognitive impairment: a systematic review. Dement. Geriatr. Cogn. Disord. 2010;29(2):164-75.
  14. Mariani E., Monastero R., Mecocci P. Mild cognitive impairment: a systematic review. J. Alzh. Dis. 12(1), 23-35 (2007).
  15. Lopez O.L., Becker J.T., Chang Y.F., et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-œgnition Study Neurol. 2012;79(15):1599-606.
  16. Sosa A.L., Albanese E., Stephan B.C., et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS. Med. 2012;9(2):e1001170.
  17. Hsu D.C., Ellison J.M. Mild Cognitive Impairment. Oxford Medicine Online. 2017. Available at: http://dx.doi.org/10.1093/ med/9780199374656.003.0032.
  18. Mitchell A.J., Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-metaanalysis of 41 robust inception cohort studies. Acta. Psychiatr. Scand. 2009;119(4):252-65.
  19. Koepsell T.D., Monsell S.E. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurol. 2012;79(15):1591-98.
  20. Fischer P., Jungwirth S., Zehetmayer S., et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurol. 2007;68(4):288-91.
  21. Clark L.R., Delano-Wood L., Libon D.J., et al. Are empirically derived subtypes of mild cognitive impairment consistent with conventional subtypes? J. Int. Neuropsychol. Soc. 2013;19(6):1-11.
  22. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004;256(3):183-94.
  23. Perneczky R., Pohl C., Sorg C., et al. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing. 2006;35(3):240-45.
  24. Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004;256(3):240-46.
  25. Petersen R.C., Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch. Neurol. 2005;62(7):1160-3, discussion 1167.
  26. Albert M.S., DeKosky S.T., Dickson D., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzh. Dement. 2011;7(3):270-79.
  27. Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999;56(3):303-8.
  28. Richard E., Schmand B.A., Eikelenboom P., Van Gool W.A. Alzheimer's Disease Neuroimaging Initiative. MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ. Open. 2013;3(6):e002541.
  29. Roberts R.O., Geda Y.E., Knopman D.S., et al. The incidence of MCI differs by subtype and is higher in men: the Mayo clinic study of aging. Neurol. 2012;78(5):342-51.
  30. Giovanetti T., Bettcher B.M., Brennan L., et al. Characterization of everyday functioning in mild cognitive impairment: A direct assessment approach. Dementia and Geriatric Cognitive Disorders. 2008;25:359-65.
  31. Morris J.C. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch. Neurol. 69(6), 700-8 (2012).
  32. Folstein M.F., Folstein S.E., McHugh P.R. «Minimental state». A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189-98.
  33. Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53(4):695-99.
  34. Левин О.С., Васенина Е.Е. Применение акатинола Мемантина в клинической практике. Современная терапия в психиатрии и неврологии. 2015;1. URL: https://cyberleninka.ru/ article/n/primenenie-akatinola-memantina-v-klinicheskoy-praktike.
  35. Uspenskaya O., Yakhno N. PO22-TH-04 Memantine hampers the progression of cognitive dysfunction and conversion to dementia in amnestic MCI patients. J. Neurol. Sci. 2009;285:S275. doi: 10.1016/s0022-510x(09)71046-9.
  36. Яхно Н.Н., Преображенская И.С., Захаров В.В. и др. Эффективность акатинола мемантина у пациентов с недементными когнитивными расстройствами. Результаты многоцентрового клинического наблюдения. Неврологический журнал. 2010;15(2):52-8.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2018
##common.cookie##